James DArecca

Insider Reports History

Entity: Individual
Location: C/O Haemonetics Corporation, 125 Summer Street, Boston, MA
Signature: /s/ Thomas V. Powers, attorney-in-fact for Mr. D'Arecca
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James DArecca:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
TherapeuticsMD, Inc.	Chief Financial Officer	Restricted Stock Units	434K	$1.58M	$3.64	Aug 10, 2021	Direct
HAEMONETICS CORP	EVP, Chief Financial Officer	Common Stock	16.7K	$1.07M	$63.85	May 2, 2025	Direct
TherapeuticsMD, Inc.	Chief Financial Officer	Performance Stock Units	347K	$601K	$1.73	Jul 1, 2021	Direct
Prestige Consumer Healthcare Inc.	Director	Common Stock, par value $0.01 per share	4.5K	$315K	$70.00	Aug 6, 2024	Direct
TherapeuticsMD, Inc.	Chief Financial Officer	Common Stock	124K	$277K	$2.24	Aug 12, 2021	Direct
HAEMONETICS CORP	EVP, Chief Financial Officer	Non-qualified Stock Option (Right to Buy)	9.76K			May 17, 2024	Direct

Showing 1 to 6 of 6 entries

Insider Reports Filed by James DArecca

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
HAE	HAEMONETICS CORP	May 2, 2025	1	-$41.8K	4	May 5, 2025	EVP, Chief Financial Officer
PBH	Prestige Consumer Healthcare Inc.	Aug 6, 2024	1	$0	4	Aug 7, 2024	Director
HAE	HAEMONETICS CORP	May 17, 2024	2	$0	4	May 21, 2024	EVP, Chief Financial Officer
HAE	HAEMONETICS CORP	May 15, 2024	2	-$73K	4	May 17, 2024	EVP, Chief Financial Officer
HAE	HAEMONETICS CORP	May 2, 2024	1	-$40.3K	4	May 6, 2024	EVP, Chief Financial Officer
PBH	Prestige Consumer Healthcare Inc.	Aug 1, 2023	1	$0	4	Aug 3, 2023	Director
PBH	Prestige Consumer Healthcare Inc.	Aug 1, 2023	0	$0	3	Aug 3, 2023	Director
HAE	HAEMONETICS CORP	May 15, 2023	3	-$31.1K	4	May 17, 2023	EVP, Chief Financial Officer
HAE	HAEMONETICS CORP	May 2, 2023	1	-$35.1K	4	May 4, 2023	EVP, Chief Financial Officer
HAE	HAEMONETICS CORP	May 16, 2022	2	$0	4	May 18, 2022	EVP, Chief Financial Officer
HAE	HAEMONETICS CORP	May 2, 2022	2	$0	4	May 4, 2022	EVP, Chief Financial Officer
HAE	HAEMONETICS CORP	Apr 11, 2022	0	$0	3	Apr 14, 2022	EVP, Chief Financial Officer
TXMD	TherapeuticsMD, Inc.	Aug 10, 2021	3	-$81.2K	4	Aug 12, 2021	Chief Financial Officer
TXMD	TherapeuticsMD, Inc.	Jul 1, 2021	2	$0	4	Jul 2, 2021	CFO